Questcor Pharmaceuticals (QCOR) Slammed as Cerium Pharmaceuticals Granted FDA Orphan Drug Status

Go back to Questcor Pharmaceuticals (QCOR) Slammed as Cerium Pharmaceuticals Granted FDA Orphan Drug Status

Citron Digs into Synthetic Acthar Filing and Finds Old Questcor (QCOR) Ties

November 2, 2012 12:05 PM EDT

Citron Research provided some insight into news today that Cerium Pharmaceuticals filed FDA orphan drug designation for Synacthen Depot (synthetic equivalent of Acthar), which has... More